We are live on ! Find out more
RMCM

Reynders McVeigh Capital Management Portfolio holdings

AUM $1.98B
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+0.35%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$1.63B
AUM Growth
+$1.24M
Cap. Flow
+$8.83M
Cap. Flow %
0.54%
Top 10 Hldgs %
35.93%
Holding
239
New
7
Increased
89
Reduced
89
Closed
17

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$3.46M
2
OTLY
Oatly Group
OTLY
+$2.87M
3
TILE icon
Interface
TILE
+$2.55M
4
TMUS icon
T-Mobile US
TMUS
+$2.51M
5
BXP icon
Boston Properties
BXP
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 25.57%
2 Technology 20.23%
3 Industrials 13.9%
4 Communication Services 11.84%
5 Consumer Discretionary 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGEN
126
DELISTED
Seagen Inc. Common Stock
SGEN
$744K 0.05%
4,381
-1,060
-19% -$165K
IWF icon
127
iShares Russell 1000 Growth ETF
IWF
$128B
$743K 0.05%
10,844
-16
-0.1% -$1.13K
DSGX icon
128
Descartes Systems
DSGX
$6.65B
$731K 0.04%
8,995
+80
+0.9% +$6.06K
SDY icon
129
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$714K 0.04%
6,077
INTU icon
130
Intuit
INTU
$91.6B
$696K 0.04%
1,291
+10
+0.8% +$5.39K
IVW icon
131
iShares S&P 500 Growth ETF
IVW
$77.3B
$670K 0.04%
9,063
MCO icon
132
Moody's
MCO
$82.8B
$648K 0.04%
1,825
+4
+0.2% +$1.51K
APD icon
133
Air Products & Chemicals
APD
$67.7B
$631K 0.04%
2,463
+28
+1% +$7.75K
PODD icon
134
Insulet
PODD
$10.1B
$618K 0.04%
2,173
+525
+32% +$150K
VEA icon
135
Vanguard FTSE Developed Markets ETF
VEA
$238B
$616K 0.04%
12,205
+4,797
+65% +$249K
CRM icon
136
Salesforce
CRM
$158B
$613K 0.04%
2,260
+175
+8% +$44.4K
PAYX icon
137
Paychex
PAYX
$42.8B
$600K 0.04%
5,337
+5
+0.1% +$562
DLN icon
138
WisdomTree US LargeCap Dividend Fund
DLN
$6.42B
$596K 0.04%
10,000
CAT icon
139
Caterpillar
CAT
$393B
$584K 0.04%
3,040
-130
-4% -$27.1K
BKNG icon
140
Booking.com
BKNG
$159B
$582K 0.04%
6,125
NTAP icon
141
NetApp
NTAP
$39.6B
$579K 0.04%
6,450
-750
-10% -$63.3K
FRC
142
DELISTED
First Republic Bank
FRC
$578K 0.04%
2,997
-633
-17% -$125K
REGN icon
143
Regeneron Pharmaceuticals
REGN
$82.2B
$568K 0.03%
939
-323
-26% -$201K
KMB icon
144
Kimberly-Clark
KMB
$36.2B
$564K 0.03%
4,262
-314
-7% -$42.7K
UNH icon
145
UnitedHealth
UNH
$364B
$549K 0.03%
1,404
-309
-18% -$128K
DTE icon
146
DTE Energy
DTE
$28.9B
$544K 0.03%
4,871
-911
-16% -$107K
QQQ icon
147
Invesco QQQ Trust
QQQ
$481B
$533K 0.03%
1,488
-263
-15% -$96.9K
XONE
148
DELISTED
The ExOne Company
XONE
$526K 0.03%
22,480
-560
-2% -$11.7K
DD icon
149
DuPont de Nemours
DD
$19.5B
$525K 0.03%
6,157
SJM icon
150
J.M. Smucker
SJM
$12.7B
$524K 0.03%
4,368
-100
-2% -$12.7K

Similar funds

Reynders McVeigh Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Reynders McVeigh Capital Management held 239 positions worth $1.63B, up 0.08% from $1.63B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Reynders McVeigh Capital Management's Q3 2021 filing shows 7 new, 89 increased, 89 reduced and 17 closed positions. Its largest new stake was Revvity: 5,324 shares worth $923K. The largest sale was Teladoc Health, an estimated $4.44M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

  • Reynders McVeigh Capital Management's largest Q3 2021 buy was Revvity: 5,324 shares worth $923K.
  • Reynders McVeigh Capital Management added most to Medtronic in Q3 2021, an estimated $3.46M increase.
  • Reynders McVeigh Capital Management's biggest Q3 2021 reduction was Teladoc Health, cutting an estimated $4.44M.
  • Reynders McVeigh Capital Management fully exited Brookfield Renewable in Q3 2021, selling an estimated $518K.
  • Reynders McVeigh Capital Management's ten largest holdings make up 36% of its $1.63B portfolio in Q3 2021.
  • Reynders McVeigh Capital Management opened 7 new positions and closed 17 in Q3 2021.
  • Reynders McVeigh Capital Management's portfolio value rose 0.08% quarter-over-quarter to $1.63B.

Based on Reynders McVeigh Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.